-
TRXB share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of TRXB shares has held flat since the market last closed. This is a 0.00% change.
-
Closed at $14.00.
The stock has since risen $0.50 in after-hours trading.
Key terms
About TRXB
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA.
-
Market cap: $384.24M
A market capitalization between $300 million and $2 billion places TRXB in the small capitalization category.
Key terms
Smart score
Latest TRXB news
TRXB Financials
-
TRXB total revenue: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
TRXB net income: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
TRXB earnings per share: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
Key terms
TRXB Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TRXB Competitors
-
How competitors are chosen
TRXB's competitors are included in the Health Technology sector and Pharmaceuticals: Major group
-
Market cap: $384.24M
A market capitalization between $300 million and $2 billion places TRXB in the small capitalization category.
